From Nasdaq:

Exxon Mobil Corporation (XOM) is expected to report a 34.71% decrease in earnings per share compared to last year, with a forecast of $2.22 per share. The 2023 Price to Earnings ratio for XOM is 11.83 vs. an industry ratio of 6.70, implying higher earnings growth than competitors.

Chevron Corporation (CVX) is expected to report a 19.07% decrease in earnings per share compared to last year, with a forecast of $3.31 per share. The 2023 Price to Earnings ratio for CVX is 12.31 vs. an industry ratio of 6.70, implying higher earnings growth than competitors.

AbbVie Inc. (ABBV) is expected to report a 23.06% decrease in earnings per share compared to last year, with a forecast of $2.77 per share. The 2023 Price to Earnings ratio for ABBV is 13.53 vs. an industry ratio of 30.40.

Cigna Group (CI) is expected to report a 31.45% increase in earnings per share compared to last year, with a forecast of $6.52 per share. The 2023 Price to Earnings ratio for CI is 11.62 vs. an industry ratio of 21.20.

Regeneron Pharmaceuticals, Inc. (REGN) is expected to report a 16.70% decrease in earnings per share compared to last year, with a forecast of $9.13 per share. The 2023 Price to Earnings ratio for REGN is 21.85 vs. an industry ratio of -1.20.

Aon plc (AON) is expected to report a 4.63% increase in earnings per share compared to last year, with a forecast of $4.07 per share. The 2023 Price to Earnings ratio for AON is 22.11 vs. an industry ratio of 22.20.



Read more: Pre-Market Earnings Report for February 2, 2024 : XOM, CVX, ABBV, BMY, CI, REGN, AON, CHTR, GWW, LYB, IMO, CHD